MACKENZIE ALEXANDER R; Executive Vice President of Pfizer, Inc. (NYSE:PFE) sold 7350 shares
Shares of Pfizer, Inc. (NYSE:PFE) traded between $33.82 and $34.13 and closed with +0.12% at $33.96. The Company traded 18.18 million shares as compared to its three months average volume of 17.74 million shares. The company has market value of $201.97B and PE ratio of 24.84. The company has 50-day of 33.30 and 200-day moving averages of $33.47. Additionally, stock has a Price/EPS Estimate Current Year ratio of 13.27 and its Price/EPS Estimate Next Year ratio is registered at 12.30.
Recent Insider Activity:
Currently the Insiders own 0.04% of Pfizer Inc. shares. Institutional Investors own 71.30% of company’s shares. During last three month period, the net percent change held by Institutional Investors has seen a change of -1.01%. During last six month period, the net percent change kept by insiders has seen a change of -18.05%.
In the company’s insider trading activities, MACKENZIE ALEXANDER R; Executive Vice President of Pfizer Inc. sold 7350 shares worth of $249900 in a transaction on 31 Aug 2017. In this transaction, these shares were sold at value of $34 per share, according to the information disclosed by the Securities and Exchange Commission in a Form 4 filing on 01 Sep 2017.
DAMELIO FRANK A; Executive Vice President of Pfizer Inc. sold 94409 shares worth of $3209906 in a transaction dated on 31 Aug 2017. Shares were sold at the average price of 34 per share, according to SEC Form 4 filing submitted on 01 Sep 2017.
In other transaction, READ IAN C (Chairman & CEO) sold 141193 shares on 31 Aug 2017 worth of $4800562. In this Insider Trading activity, shares were sold with per share cost of $34.
READ IAN C (Chairman & CEO) of PFE [NYSE] sold 55975 shares worth of $1903150 at the average price of $34 on31 Aug 2017.
On 21 Aug 2017, OLSON LAURIE J (Executive Vice President) sold 8064 shares at per share price of $32.7 with total value of $263693.
Analyst projected earnings per shares (EPS) of $2.76 for next Year. They forecasted earnings per share (EPS) of $2.56 for current Year and also expected EPS of $0.56 for coming quarter.